JACQUELINE SEBASTIAN: Open Payments
NPI 1386752228 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 27 payments from 12 companies in 2025. Trend: 2023 $569 · 2024 $620 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $160 |
| Fresenius USA Marketing, Inc. | 5 | $115 |
| Calliditas Therapeutics US Inc. | 2 | $63 |
| Ardelyx, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: VELPHORO, KRYSTEXXA, TAVNEOS, TARPEYO, IBSRELA, JARDIANCE, FARXIGA, JYNARQUE.
Industry payments across NC — which companies pay providers there.
